Skip to main content
SellModerate Confidence
Investment thesis

FTHY sits below the platform's quality floor amid declining revenue and margin compression, with overbought technicals and an elevated risk score adding further caution despite a nominally cheap valuation.

Thesis pillars

  • Quality Below Floor Revenue Decline→Stable
  • Overbought Technicals Falling Volume↑Improving
  • Elevated Risk Profile→Stable
  • +1 more pillar — see the Why tab for full reasoning

Pillars as of Jul 5, 2026

Full reasoning →

Open full analysis

FTHY (FTHY) Stock Analysis

Momentum Cont setup

SellShortModerate Confidence

Financial Services · Asset Management

Sell if holding. Engine safety override at $13.03: Quality below floor (0.9 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.0/10. Specifically: Below-average business quality.

$13.03+15.0% A.UpsideScore 5.0/10#182 of 229 Asset Management
QualityF-score0 / 9FCF yield—
IncomeYield11.51%(5y avg 10.51%)Payout217.39%at-risk
Stop $12.65Default target $14.98A.R:R 0.0:1

Sell if holding. Engine safety override at $13.03: Quality below floor (0.9 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.0/10. Specifically: Below-average business quality. Chart setup: Trend continuation, RSI 64, MACD bullish. Score 5.0/10, moderate confidence.

Passes 7/9 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity no date, semi cycle peak clear, materials cycle peak clear). Suitability: aggressive.

Thesis

Rewards
No bull case signals
Risks
Quality below floor (0.9 < 4.0)

Key Metrics

P/E (TTM)18.9
P/E (Fwd)—
Mkt Cap$479M
EV/EBITDA—
Profit Mgn0.0%
ROE—
Rev Growth—
Beta—
Dividend11.51%
Rating analysts—

Quality Signals

Piotroski F0/9

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

2 floor-breakers·1 ceiling hit

Quality below the gate floor. Component breakdown shows what dragged the score down.static

Gross Margin
0.0
Operating Margin
0.0
Net Margin
0.0
Piotroski F
0.0
Moat
4.5
No competitive moatWeak Piotroski F-Score: 0/9Quality concerns

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Bollinger
0.0
Support Resistance
1.0
52w Position
9.5
GatesA.R:R UPSIDE_EXHAUSTED (upside=0.0%)Death cross (50MA < 200MA)Momentum 6.1>=5.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY NO DATESEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARMomentum ContSuitability: Aggressive
RSI
64 · Neutral
↑ 20D MA↑ 50D MA↑ 200D MADEATH CROSSSupport $12.49Resistance $13.09

Price Targets

$13
$15
A.R:R0.0:1

Position Sizing

ConvictionNone
Suggested %0%
Max %0%
RegimeSteady

Risk Alerts

! Quality below floor (0.9 < 4.0)

Earnings

We could not retrieve earnings history for FTHY.
The company may be recently listed, pre-revenue, or its beat/miss record wasn't available from our source this run. Earnings signals feed the Growth and Catalyst score dimensions — absence here doesn't affect other dimensions.

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is FTHY stock a buy right now?

Sell if holding. Engine safety override at $13.03: Quality below floor (0.9 < 4.0) triggers a hard block regardless of the otherwise-positive setup — overall score 5.0/10. Specifically: Below-average business quality. Chart setup: Trend continuation, RSI 64, MACD bullish. Prior stop was $12.65. Score 5.0/10, moderate confidence.

What is the FTHY stock price target?

Default target: $14.98 (+15.0% upside). Prior stop was $12.65. Stop-loss: $12.65.

What are the risks of investing in FTHY?

Quality below floor (0.9 < 4.0).

Is FTHY overvalued or undervalued?

FTHY trades at a P/E of 18.9 (forward N/A). TrendMatrix value score: 6.8/10. Verdict: Sell.

0
Related stocks: GAB (Gabelli Equity Trust, Inc. (The) · CII (BlackRock Enhanced Large Cap Co) · TWN (Taiwan Fund, Inc. (The)) · FFA (First Trust Enhanced Equity Inc) · ADX (Adams Diversified Equity Fund I)
Home › Stocks › FTHY

Latest news

No recent news